tradingkey.logo

United-Guardian Inc

UG
查看详细走势图
6.090USD
+0.030+0.50%
收盘 12/19, 16:00美东报价延迟15分钟
27.98M总市值
14.28市盈率 TTM

United-Guardian Inc

6.090
+0.030+0.50%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.50%

5天

+1.00%

1月

+5.00%

6月

-25.55%

今年开始到现在

-36.30%

1年

-37.09%

查看详细走势图

TradingKey United-Guardian Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

United-Guardian Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在药品行业排名107/158位。机构持股占比非常高,中期看,股价处于下降通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

United-Guardian Inc评分

相关信息

行业排名
107 / 158
全市场排名
301 / 4582
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

United-Guardian Inc亮点

亮点风险
United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
业绩增长期
公司处于发展阶段,最新年度总收入12.18M美元
利润高增长
公司净利润处于行业前列,最新年度总收入12.18M美元
高分红
公司属于高分红公司,最新股息支付率84.79%
稳定分红
公司5年内连续分红,最新股息支付率84.79%
估值合理
公司最新PE估值14.28,处于3年历史合理位
机构减仓
最新机构持股1.05M股,环比减少4.12%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值184.76K

United-Guardian Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

United-Guardian Inc简介

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.
公司代码UG
公司United-Guardian Inc
CEO
网址https://u-g.com/

常见问题

United-Guardian Inc(UG)的当前股价是多少?

United-Guardian Inc(UG)的当前股价是 6.090。

United-Guardian Inc的股票代码是什么?

United-Guardian Inc的股票代码是UG。

United-Guardian Inc股票的52周最高点是多少?

United-Guardian Inc股票的52周最高点是11.980。

United-Guardian Inc股票的52周最低点是多少?

United-Guardian Inc股票的52周最低点是5.575。

United-Guardian Inc的市值是多少?

United-Guardian Inc的市值是27.98M。

United-Guardian Inc的净利润是多少?

United-Guardian Inc的净利润为3.25M。

现在United-Guardian Inc(UG)的股票是买入、持有还是卖出?

根据分析师评级,United-Guardian Inc(UG)的总体评级为--,目标价格为--。

United-Guardian Inc(UG)股票的每股收益(EPS TTM)是多少

United-Guardian Inc(UG)股票的每股收益(EPS TTM)是0.427。
KeyAI